The Strongest Alliance for the Finest Products
”Together with Samsung Pharm, Korea's premier pharmaceutical company,
BOSU Co., Ltd. brings its accumulated expertise and know-how to protect the health of the nation.
With robust technology and innovative R&D, we are spreading the name of Korea Seoganwon to the world.
Founded on August 15, 1929, under the philosophy of "Protecting the Health of the Nation,"
Samsung Pharm holds human life as its most precious and highest value.
We will spare no effort in developing cutting-edge pharmaceuticals to promote public health and eradicate disease.
Since its founding, Samsung Pharm has manufactured over 200 types of medicines and has built its reputation as a trusted company through landmark products such as 까스명수, 쓸기담, and 우황청심원. In particular, obtaining marketing approval for Liavex in 2015 established us as a specialized pharmaceutical company with an anti-cancer pipeline. We will continue building a portfolio across the bio industry, including health foods and cosmetics, to create high-value product lines for the global market.
Not content to rest on past achievements, Samsung Pharm will continue to develop and grow superior medicines that enhance "quality of life," building on our accumulated technology and experience. Through continuous, intensive innovation and improvement, we will advance as a global Samsung Pharm — moving forward into the world in a rapidly changing environment.
Samsung Pharm Co., Ltd. practices the belief that life is the very foundation of all human existence. By placing emphasis on human dignity and respect, we strive to earn the trust of our customers through the highest quality, the finest technology, and perfect customer satisfaction.
Having grown through numerous challenges, Samsung Pharm will continue to practice ethical and transparent management, while pursuing diversification of sales and operations based on our best-fit marketing expertise.
Samsung Pharm is investing heavily in advanced manufacturing technology and new drug development. Investment in our research institute and new drug development is the driving force that allows us to hold our ground firmly, even in an increasingly competitive pharmaceutical market.